Ritu Salani MD MBA
Gynecologic Oncology
Professor, Obstetrics and Gynecology, University of California, Los Angeles
Join to View Full Profile
100 Medical Plaza, Suite 383Los Angeles, CA 90095
Phone+1 310-794-7274
Fax+1 310-794-7274
Dr. Salani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Gynecologic Oncology, 2005 - 2008
Emory University School of MedicineResidency, Obstetrics and Gynecology, 2001 - 2005
Northeast Ohio Medical UniversityClass of 2001
Certifications & Licensure
CA State Medical License 2020 - 2026
OH State Medical License 2008 - 2022
MD State Medical License 2006 - 2009
GA State Medical License 2003 - 2005
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian Start of enrollment: 2010 Sep 01
- Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Start of enrollment: 2011 Mar 14
Publications & Presentations
PubMed
- Association of sexual pain and psychological factors among gynecologic and breast cancer patients: application of components of the fear-avoidance model of chronic pain.Lora L Black, Katherine Conroy, Maryam Lustberg, Ritu Salani, Barbara L Andersen
Journal of Behavioral Medicine. 2025-03-13 - Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.Stéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong, William A Cliby, Mitchell I Edelson
Journal of Clinical Oncology. 2025-03-01 - Real-world duration of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer in the United States: the CHAR1ZMA study.Floor J Backes, Tirza Areli Calderón Boyle, Jonathan Lim, John Hartman, Jeanne M Schilder
International Journal of Gynecological Cancer. 2025-02-01
Journal Articles
- An Ecological Evaluation of the Increasing Incidence of Endometrial Cancer and the Obesity EpidemicStacy A Smrz, Corinne Calo, Ritu Salani, American Journal of Obstetrics and Gynecology
Authored Content
- Disappointing but Important: Cervical Cancer OUTBACK Trial’s Negative ResultsJune 2021
Press Mentions
Presidential Matters: Amanda Nickles Fader, MDFebruary 10th, 2025- SGO Ways to Wellness: An Open Letter to My Former SelfJanuary 6th, 2025
- CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian CancerMarch 26th, 2023
- Join now to see all
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
